Transparency and the drug approval process at Health Canada

Text Size: Normal / Medium / Large
Printer-friendly versionPrinter-friendly version
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type: 
Online
Author: 
Ann Silversides
Publisher: 
Women and Health Protection
Publication Date: 
2005
Publication Place: 
Toronto, ON

Argues that the federal government is protecting drug companies instead of the public by keeping information about the drug approval process secret. Examines the impact of this on women's health.

Available From: 
ISBN/ISSN: 
WHP PHAR.S55 2005
Notes: 
Includes bibliographical references.